These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 15266473)

  • 21. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.
    Massie BM; Krol WF; Ammon SE; Armstrong PW; Cleland JG; Collins JF; Ezekowitz M; Jafri SM; O'Connor CM; Packer M; Schulman KA; Teo K; Warren S
    J Card Fail; 2004 Apr; 10(2):101-12. PubMed ID: 15101020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence with antiplatelet therapy and ADP-receptor antagonists.
    Easton JD
    Cerebrovasc Dis; 2003; 16 Suppl 1():20-6. PubMed ID: 12698015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB
    Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulants versus antiplatelet agents for acute ischaemic stroke.
    Berge E; Sandercock P
    Cochrane Database Syst Rev; 2002; (4):CD003242. PubMed ID: 12519590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
    Little SH; Massel DR
    Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet therapy in populations at high risk of atherothrombosis.
    Faxon DP; Nesto RW
    J Natl Med Assoc; 2006 May; 98(5):711-21. PubMed ID: 16749646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
    Yuan C; Zhong L; Huang RC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):526-535. PubMed ID: 28648031
    [No Abstract]   [Full Text] [Related]  

  • 29. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombotic therapy after cerebral ischemia].
    Schellinger PD; Orberk E; Hacke W
    Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.
    Zhao HJ; Zheng ZT; Wang ZH; Li SH; Zhang Y; Zhong M; Zhang W
    Chest; 2011 Feb; 139(2):260-270. PubMed ID: 21285053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001938. PubMed ID: 17636690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
    Massel DR; Little SH
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003464. PubMed ID: 23839768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):451-9. PubMed ID: 12096150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic drugs for carotid artery dissection.
    Lyrer P; Engelter S
    Cochrane Database Syst Rev; 2000; (4):CD000255. PubMed ID: 11034680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Sudlow CL; Mason G; Maurice JB; Wedderburn CJ; Hankey GJ
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD001246. PubMed ID: 19821273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.